Delsym and Pulmicort drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Delsym (dextromethorphan polistirex) and Pulmicort (budesonide). Common drug interactions include pneumonia among females and productive cough among males.

The phase IV clinical study analyzes what interactions people have when they take Delsym and Pulmicort. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Delsym?

Delsym has active ingredients of dextromethorphan polistirex. It is often used in cough. eHealthMe is studying from 5,033 Delsym users. Check the latest studies of Delsym.

What is Pulmicort?

Pulmicort has active ingredients of budesonide. It is often used in asthma. eHealthMe is studying from 34,980 Pulmicort users. Check the latest studies of Pulmicort.

On Jul, 28, 2026

19 people who take Delsym and Pulmicort together, and have interactions are studied.

What are the common drug interactions of Delsym and Pulmicort, by gender? *:

female:

Pneumonia
Sinusitis (inflammation of sinus)
Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
Fatigue (feeling of tiredness)
Infusion site pain
Post procedural discharge
Contusion (a type of hematoma of tissue in which capillaries)
Infusion site bruising
Infusion site erythema (reddening of the skin at infusion site)
Infusion site pruritus (severe itching at infusion site)

male:

Productive cough
Respiratory tract infection
Coagulopathy (blood's ability to clot is impaired)
Erythema (redness of the skin)
Pancreatic carcinoma metastatic (pancreatic cancer- metastatic)
Renal failure (kidney dysfunction)
Upper respiratory tract infection
Sinusitis (inflammation of sinus)
Decreased appetite
Hypersensitivity

What are the common drug interactions of Delsym and Pulmicort, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Productive cough
Respiratory tract infection
Sinusitis (inflammation of sinus)
Erythema (redness of the skin)
Pneumonia
Upper respiratory tract infection

10-19:

Decreased appetite
Hypersensitivity
Swollen tongue (swelling of tongue)
Tongue disorder (disease of tongue)
Vomiting
Bilirubin conjugated increased
Eye disorder
Hepatic mass
Hepatocellular carcinoma (liver cancer)
Ocular icterus (presence of jaundice seen in the sclera of the eye)

20-29:

n/a

30-39:

n/a

40-49:

Pneumonia
Adverse drug reaction
Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
Fatigue (feeling of tiredness)
Infusion site bruising
Infusion site pain
Post procedural discharge
Sinusitis (inflammation of sinus)
Constipation
Contusion (a type of hematoma of tissue in which capillaries)

50-59:

Contusion (a type of hematoma of tissue in which capillaries)
Fatigue (feeling of tiredness)
Feeling hot
Impaired gastric emptying
Infection
Infusion related reaction
Infusion site erythema (reddening of the skin at infusion site)
Infusion site haemorrhage (bleeding from infusion site)
Infusion site pain
Infusion site pruritus (severe itching at infusion site)

60+:

Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Abdominal wall haematoma (abdominal wall blood clotting)
Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Chronic kidney disease
Coagulopathy (blood's ability to clot is impaired)
Death
Malaise (a feeling of general discomfort or uneasiness)
Pancreatic carcinoma metastatic (pancreatic cancer- metastatic)
Renal failure (kidney dysfunction)

What are the existing conditions these people have? *

Immunodeficiency Common Variable: 10 people, 52.63%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 15.79%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 15.79%
Nausea (feeling of having an urge to vomit): 2 people, 10.53%
Cholangiocarcinoma (a cancer that forms glands or secretes significant amounts of mucins): 2 people, 10.53%
Constipation: 2 people, 10.53%
Glaucoma (increased fluid pressure in the eye with vision loss): 2 people, 10.53%
Headache (pain in head): 2 people, 10.53%
Insomnia (sleeplessness): 2 people, 10.53%
Abdominal Pain: 2 people, 10.53%

* Approximation only. Some reports may have incomplete information.

Do you take Delsym and Pulmicort?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously